Anyone more learned than myself who can provide the current status of our Fragile X trial? Last i can seem to find is the Chairman's address release on 29/06/2017 in which Dr T mentioned they are designing the next clinical trial. No updates on this. I feel the Rett valuation for a deal would be a fait accompli. The Fragile X is the unknown and would be the complex negotiating points.
- Forums
- ASX - By Stock
- NEU
- departure director
NEU
neuren pharmaceuticals limited
Add to My Watchlist
1.55%
!
$16.52
departure director, page-9
-
Top Stories
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
